[1]
Hu H, Pasca I. Management of complex cardiac issues in the pregnant patient. Crit Care Clin 2016; 32(1): 97-107.
[2]
Viaris de Lesegno B, Nelson-Piercy C. Advances in the management of cardiovascular disease during pregnancy. Future Cardiol 2018; 14(4): 269-72.
[3]
Hemlata GoyalP, Tewari S, Chatterjee A. Anaesthetic considerations for balloon mitral valvuloplasty in pregnant patient with severe mitral stenosis: A case report and review of literature. J Clin Diagn Res JCDR 2017; 11(9): Ud01-ud3.
[4]
Peng W, Jia Y. Severe mitral stenosis in term pregnancy: Management by simultaneous cesarean section and mitral valve replacement. Case report. Clin Exp Obstet Gynecol 2017; 44(2): 277-8.
[5]
Ek M, Vladic-Stjernholm Y, Gunther A, Hallsjo-Sander C, Jacobsen PH. Rheumatic heart disease behind life-threatening heart failure in pregnancy. Lakartidningen 2016; 113: 1.
[6]
Wu W, Chen Q, Zhang L, Chen W. Epidural anesthesia for cesarean section for pregnant women with rheumatic heart disease and mitral stenosis. Arch Gynecol Obstet 2016; 294(1): 103-8.
[7]
Celik M, Dostbil A, Alici HA, et al. Anaesthetic management for caesarean section surgery in two pregnant women with severe pulmonary hypertension due to mitral valve stenosis. Balkan Med J 2013; 30(4): 439-41.
[8]
Elassy SM, Elmidany AA, Elbawab HY. Urgent cardiac surgery during pregnancy: A continuous challenge. Ann Thorac Surg 2014; 97(5): 1624-9.
[9]
Benali Zel A, Ahmaidi H, Rachidi K, Omari D. Mitral stenosis with term pregnancy: How to manage this case? Pan Afr Med J 2013; 14: 144.
[10]
Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001; 37(3): 893-9.
[11]
Silversides CK, Colman JM, Sermer M, Siu SC. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol 2003; 91(11): 1382-5.
[12]
Vaughan G, Tune K, Peek MJ, et al. Rheumatic heart disease in pregnancy: strategies and lessons learnt implementing a population-based study in Australia. Int Health 2018; 10(6): 480-9.
[13]
Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001; 104: 515-21.
[14]
Jasper R, Skelding K. Cardiovascular disease risk unmasked by pregnancy complications. Eur J Intern Med 2018; 57: 1-6.
[15]
Swan L, Lupton M, Anthony J, et al. Controversies in pregnancy and congenital heart disease. Congenit Heart Dis 2006; 1(1-2): 27-34.
[16]
French KA, Poppas A. Rheumatic heart disease in pregnancy: global challenges and clear opportunities. Circulation 2018; 137(8): 817-9.
[17]
van den Akker T, Bloemenkamp KWM, van Roosmalen J, Knight M. Classification of maternal deaths: Where does the chain of events start? Lancet 2017; 390(10098): 922-3.
[18]
Benatta NF, Batouche DD, Djazouli MA, et al. Management of mitral valve stenosis during pregnancy at the Oran university hospital center: About 83 cases. Ann Cardiol Angeiol 2018; 67(4): 274-9.
[19]
Russell EA, Walsh WF, Costello B, et al. Medical management of rheumatic heart disease: A systematic review of the evidence. Cardiol Rev 2018; 26(4): 187-95.
[20]
van Hagen IM, Thorne SA, Taha N, et al. Pregnancy outcomes in women with rheumatic mitral valve disease: Results from the registry of pregnancy and cardiac disease. Circulation 2018; 137(8): 806-16.
[21]
Goldstein SA, Ward CC. Congenital and acquired valvular heart disease in pregnancy. Curr Cardiol Rep 2017; 19(10): 96.
[22]
Ford AA, Wylie BJ, Waksmonski CA, Simpson LL. Maternal congenital cardiac disease: Outcomes of pregnancy in a single tertiary care center. Obstet Gynecol 2008; 112(4): 828-33.
[23]
Cross S, Bell JS, Graham WJ. What you count is what you target: the implications of maternal death classification for tracking progress towards reducing maternal mortality in developing countries. Bull World Health Organ 2010; 88(2): 147-53.
[24]
Baumgartner H, Falk V, Bax JJ, et al. ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38(36): 2739-91.
51
2